Showing 1 - 3 results of 3 for search 'Harnicar S', query time: 0.02s Refine Results
  1. 1
    Spotlight on nilotinib in the treatment of chronic myelogenous leukemia

    Spotlight on nilotinib in the treatment of chronic myelogenous leukemia by Harnicar S, Mathew S

    Published 2014-08-01
    Get full text
    Article
  2. 2
    Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors

    Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors by Liu D, Offin M, Harnicar S, Li BT, Drilon A

    Published 2018-07-01
    Get full text
    Article
  3. 3
    Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment

    Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment by Dazhi Liu, Michael A. Weintraub, Christine Garcia, Marcus D. Goncalves, Ann Elizabeth Sisk, Alissa Casas, James J. Harding, Stephen Harnicar, Alexander Drilon, Komal Jhaveri, James H. Flory

    Published 2022-04-01
    Get full text
    Article

Search Tools: